Use of an Internet-Based Self-Screening Program to Screen for Chlamydia and Gonorrhea Wendy Voet On Behalf Of Charlotte A. Gaydos and Karen Dwyer, Mathilda.

Slides:



Advertisements
Similar presentations
RESULTS: After Discordant Analysis RESULTS: Discordant Testing
Advertisements

John Harrison, Michelle Garassi, Sara Wierzbicki, William LeBar Hospital Consolidated Laboratories-Providence Hospital, Southfield, MI, Evaluation of the.
Number of specimens tested
Clearance of Chlamydial Ribosomal RNA by APTIMA Combo 2® Testing in Women With Chlamydia Treated with Azithromycin C.A. Renault, 1 D.M. Israelski, 1 V.
PREVALENCE OF CHLAMYDIA TRACHOMATIS, NEISSERIA GONORRHOEAE AND TRICHOMONAS VAGINALIS IN YOUNG WOMEN IN KENYA USING THE GEN-PROBE APTIMA ASSAYS J Moncada.
Use of Gen-Probe APTIMA Tests to Detect Multiple Etiologies of
Transmission of Chlamydia trachomatis between heterosexual sex partners PRELIMINARY RESULTS FROM A GENOTYPE-SPECIFIC CONCORDANCE STUDY.
The Need for Sexually Transmitted Disease Screening in School-Based Health Centers M Nsuami 1, SN Taylor 1, LS Sanders 1, TA Farley 2, DH Martin 1 1 Louisiana.
Repeat Chlamydia trachomatis: Rate and Predictors among Males Eileen F. Dunne M.D., M.P.H. JB Chapin, C Rietmeijer, CK Kent, J Ellen, C Gaydos, N Willard,
Repeat Infections among Adolescents and Young Adults: Findings From Philadelphia STD Clinics Nicole Liddon, PhD 1 Michael Eberhart, BS 2 Jami Leichliter,
Enhanced Behavioral Surveillance Lessons Learned for Gonorrhea Control 2004 National STD Prevention Conference Philadelphia, PA March 2004.
Risk Factors for Early Syphilis Among Men Who Have Sex With Men Seen in an STD Clinic – San Francisco, STD Prevention Conference: March 10, 2004.
Focus on Kids Intervention for Adolescents in High School to Prevent STDs/HIV Charlotte A. Gaydos, Dr.P.H. Johns Hopkins University Baltimore, Maryland.
S L I D E 0 Sexually Transmitted Infections in adolescents Deepa Camenga, MD, MHS, FAAP Instructor of pediatrics, adolescent medicine Yale School of Medicine.
Feasibility of STD Control for HIV Prevention: Findings from Three Southern Cities NEW ORLEANS: Thomas Farley & Deborah Cohen BALTIMORE: Anne Rompalo,
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Region II Infertility Prevention Project New York City, New York December 12-13, 2007 Richard Steece, Ph.D., D(ABMM) National Infertility Prevention Project.
A Cost-Effectiveness Evaluation of the Sexually Transmitted Disease (STD) Prevention Program at the Hampden County Correctional Center, Massachusetts Gift.
Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.
1 Pathfinder Chlamydia Screening Pilot Presented by Rebecca Adeojo on behalf of : Danielle Mercey (1) Tina Sharp (2) Jill Martin (3) Julie Hamner (4) 1)
Self-Collected Vaginal Specimens for the Detection of Multiple STIs in Adolescent Detainees Cynthia M. Holland, M.D., M.P.H., Harold C. Wiesenfeld, M.D.,
Revision of Region II IPP Screening Criteria May 16, 2007 Region II IPP Advisory Committee Meeting Cicatelli Associates Inc. New York City.
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
A comparison of three different strategies to treat partners of men with urethritis Patty Kissinger 1 Gwangi Richardson-Alston 1 Jami S Leichliter 4 Hamish.
Repeat Chlamydial Infections in Region III Family Planning Clinics: Implications for Screening Programs Pamela G. Nathanson, Family Planning Council, Inc.
Region I Advisory Board Meeting Wells Beach, ME June 9, 2008 Use and Verification of STD Nucleic Acid Amplification Tests for non-FDA Cleared Clinical.
Rik Koekenbier, Fennema H, Leent van E, Zuilhof W, Veen van E, Davidovich U Online Research and Prevention unit Amsterdam Public Health Service Research.
2014 PATIENT HISTORY How would you diagnose and screen Miranda? How would you treat Miranda? Are there any additional steps you would take? Antimicrobial.
Changes in Sex Networks and Repeat STDs among Male Adolescents and Young Adults Jonathan M Ellen 1, Charlotte Gaydos 1, Michelle Chung 1, Nancy Willard.
Screening males for chlamydial infection in high schools Charlotte Gaydos, Dr.P.H. Johns Hopkins University Baltimore, Maryland.
Chlamydia trachomatis testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Chlamydia trachomatis? Chlamydia.
Evaluation of Gonorrhea Screening in Family Planning Settings: California 2000 CK Kent, M Brammeier, G Bolan, N Casas, M Funabiku, P Blackburn Region IX.
Sexual Risk Behaviors and Sexually Transmitted Infection (STI) Prevalence in an Outpatient Psychiatry Clinic LH Bachmann 1,2, J Feldman 1, Y Waithaka 1.
STEP UP: NYC DOHMH STD School Screening Progress Meighan Rogers, MPH IPP Region II Mtg December, 2007.
RTI International is a trade name of Research Triangle Institute Untreated chlamydial infection among adolescents and young adults in Baltimore,
Northwest Portland Area Indian Health Board
Faiza Ali MD, Ericka Hayes MD, Gaurav Kaushik MPH, Nicole Carr RN, Katie Plax MD Washington University School Of Medicine Department of Pediatrics.
Increasing the Efficiency of STI Clinics by Tailoring Services Based on a Risk Triage System Julie A. Subiadur, BSN, CCRC BC Brandy Mitchell, RN Dean McEwen.
US Virgin Islands IPP: Use of Limited Resources Taetia Phillips-Dorsett, MS Territorial Director, USVI DOH STD/HIV/TB Program Region II IPP Advisory Meeting.
Chlamydial Infections in the U.S. Steven J Shapiro CCID/NCSHHSTP/DSTDP/PTB Region I Infertility Prevention Project Wells Beach, Maine June 2, 2009 Disclaimer:
STI’s and the Internet Kees Rietmeijer, MD, PhD Denver Public Health Department Denver, CO, USA Risks and Opportunities for Prevention.
SSuN Cycle 2 SSuN Part B Laboratory Component: Trichomonas Resistance Evaluation Bob Kirkcaldy, Lori Newman, Kristen Mahle December 4, 2008.
“ Gonorrhea Screening Strategies and Guideline Development for Non-Pregnant Female Patients in the California Family Planning Clinic Setting ” Holly Howard,
Pilot Study: Re-screening Adolescent and Young Adult Women for Chlamydia Infection Alison Muse NYSDOH Bureau of STD Control Region II IPP meeting November.
Region II IPP Data & Infrastructure Performance Measures Kelly Opdyke, MPH Region II IPP Advisory Committee Mtg May 16-17, 2007 Cicatelli Associates Inc.
IPP Measures of Effectiveness Utilization of Data to Evaluate and Inform Project Activities December 12, 2007 Kelly Morrison Opdyke, MPH Region II Infertility.
Evaluation of Presumptive Treatment Recommendation for Asymptomatic Anorectal Gonorrhoea and Chlamydia Infections in At-Risk Kenyan MSM IAS 24 July 2012.
Self-reported Risk History in Women Using an Internet-based Screening Program for Chlamydia trachomatis Using Self- collected Vaginal Swabs Returned by.
Targeting Chlamydia Screening Resources Region II IPP Advisory Meeting May 31, 2006 Kelly Opdyke, MPH Cicatelli Associates Inc.
By: Hayley MacDonald and Morgan Dolak
Gonorrhea Morbidity and Prevention Efforts in Los Angeles County Binh Goldstein, PhD, Epidemiologist Sarah Guerry, MD, Medical Director Sexually Transmitted.
High prevalence rate of Trichomoniasis Vaginalis in an urban HIV clinic Debbie Mohammed, DrPH, MS, MPH, AACRN Prerak Shukla, MBBS Maria Szabela, MD Jihad.
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
What is Chlamydia?. Chlamydia Bacterial sexually transmitted infection (STI) Most common STI throughout the world 1 in 10 sexually active 15 – 25 years.
The Dublin Well Woman Centre and The National Virus Reference Laboratory  Approved by ICGP Ethics Committee.
Rodney C. Perkins 1, Grace K. Douglass 2, Victoria C. Ta 2, Aurnell Dright 1, Michael Fomundam 2, Ying Li 3, Michael Plankey 3 Sexually Transmitted Infection.
Evaluation of 5 different tests for Trichomonas vaginalis infection and cost effective planning for clinical implementation B. Nathan 1, J Appiah 2, D.
CHLAMYDIA TRACHOMATIS – DIAGNOSIS AND MANAGEMENT Jess Gaddie (adapted from presentation by Rachel Coyne)
Risk Behaviour, Health Care Access and Prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoea in a population based sample of.
Seeking HIV-testing Only: Missed Opportunity for HIV Prevention?
Vaginal Swabs Clinical Information Why? Murray Robinson
Rectal chlamydia infection in women Have we been missing the point?
J. Mossong1, N. Majéry2, C. Mardaga3 , M. Muller4, F. Schneider1
Can Self-collected Vaginal Swabs Facilitate Testing for Repeat Chlamydia trachomatis Infections among STD Clinic Clients Good morning everyone! I am going.
Region II IPP Performance Measure IPP CS1 and IPP CS2 Project Area Trend Report IPP CS1: Timely treatment of women with chlamydia at IPP Family Planning.
Richard Steece, Ph.D., D(ABMM) National Infertility Prevention Project
Nucleic Acid Amplification Tests for the Diagnosis of Chlamydia trachomatis Rectal Infections Bachmann LH1,2, Johnson R3, Cheng H1, Markowitz L3, Papp.
M. Jacques Nsuami, MD, MPH Stephanie N. Taylor, MD
Screening Protocols and Education Charlotte A. Gaydos, MS, MPH, DrPH
Presentation transcript:

Use of an Internet-Based Self-Screening Program to Screen for Chlamydia and Gonorrhea Wendy Voet On Behalf Of Charlotte A. Gaydos and Karen Dwyer, Mathilda Barnes, Billie Jo Wood, Toni Flemming, Patricia RizzoPrice, Catherine Wright, Dawn Middleton, Terry Hogan

OBJECTIVES To implement an Internet project to facilitate home screening for CT and GC To encourage women to obtain and use self-administered vaginal swabs (SAS) To measure STD prevalence and risk factors of women who used SAS

Objectives Continued… To measure opinions and perceptions of the women participants about home screening

METHODS-Use of the Kit Website at: Kits containing consent form, swab, instructions, questionnaire, contact form and mailer Clinic Network in Place for Treatment 800 Number Available for Clients to Access Results

Methods – Use of Kit Continued… Publicity: City Paper, Smart Woman Magazine, Radio, Flyers 1,254 kits in pharmacies & community (discontinued) 2,418 kits mailed to homes from /phone requests since July 2004

METHODS- Use of the Kit Each swab tested by multiple nucleic acid amplification tests (NAATs) for CT & GC PCR (Roche): Amplicore (dropped after n=500) SDA (Becton Dickinson): Probetec TMA (GenProbe): Aptima Combo2 Two different positive NAAT results required to call a sample positive

RESULTS- Use of the Kit Of 778 tested through Jan 31, (9.2%) CT positive* 12 (1.3%) GC positive *(4 co-infected w/ CT and GC) Of 115 tested for Trichomonas since September, 13 (11.3%) positive** ** (1 co-infected w/ CT and GC)

RESULTS- Use of the Kit CT: 66/69 (95.6%) confirmed treated GC: 11/11 (100%) confirmed treated Range of those participants years Median age of SAS submitters was 23 years Positives: median age 19 yr Negatives: median age 23.0 yr

CT Prevalence: Results by Race n = 752* 5.2% Infected 70.0% 22.5% 7.7% *8 did not report race; Black Race vs. All Others, p = Of 69 total positives, Black: 62 (90%), White: 4 (5.8%), Other: 3 (4.3%),

CT Prevalence: Results by Age n = 756* 8.5% Infected 8.0% Infected 16.8% Infected 31.2% *4 did not report age. There were 9 women 14 yr old, all were chlamydia negative 1.3% Infected 19.8%

Internet Prevalence vs. Baltimore and Maryland Family Planning Clinics Prevalence Age (yr)N Internet Project 2004 – 2005 Family Planning Clinics (n=567) Baltimore (n=3,166) Maryland (n=34,525) Baltimore (n=3,449) Maryland (n=33,873) %13.3%4.8%5.6%5.2% %12.0%7.3%9.7%7.3% %8.1%4.4%6.7%4.4% %2.6%2.3%3.6%1.9% > %2.8%1.1%1.5%0.8% Total564***9.0%4.9%4.0%4.4%4.0%

Univariate Analysis of Demographics & Risk Factors (N= 760) Black Race vs. White (p = 0.001) Age 25 yr. (p = ) Multiple partners (p = 0.017) Hx GC (p = 0.02) Univariate logistic regression: significant differences between infected & uninfected women

Symptoms Results All Women (N =756) (p > between infected vs. uninfected each symptom) Vaginal discharge was common: 47.2% Lower abdominal pain: 18.1% Pain during urination: 5.6% Pain during intercourse: 14.4% Abnormal vaginal bleeding: 6.9% Any symptoms: 61.4% No symptoms: 38.6%

Questionnaire Results: Preference for Sample Type (N=745) Pelvic 17.9% Urine 8.1% Vaginal or Urine 12.1% Self Vaginal 50.1% Other Combo 11.8%

Questionnaire Results: Preference for Receiving Results (N=744) Call 800 number 10.9% U.S. Mail 9.0% 25.5% Secure Internet 32.5% Other Combo 9.7% Phone 12.4%

Questionnaire Results SAS Collection 96%98.2%93.5%

CONCLUSIONS- Use of the Kit Use of the Internet and request for kits supported the concept of a chlamydia website that could offer educational information encourage use of SAS home sampling Most collection kits were requested Women will request and use SAS kits High prevalence of chlamydia was found High level of risk behavior noted

CONCLUSIONS- Use of the Kit The Internet recruitment method may help screen women who otherwise would not get tested for chlamydia Treatment of infected women was possible Women rated SAS use & Internet screening easy to very easy; would use again Prevalence higher than in family planning clinics in Baltimore and Maryland

Preliminary Male Data Men testing recently added (urine and penile swab) All men except one submitted both urine and penile swab (acceptability good for self penile swabs) GenProbe APTIMA Combo 2 used for CT and GC GenProbe ASR Trichomonas test used for Trich  Ct 36.8% (of 23 submitted)  GC 0%  Trich 0%

Programming Considerations and Budget Potential need for IRB 10-20% of staff time (IPP Coordinator?) It costs $6 per kit. In MD, they had 1,000 requests last year with a 34% return rate Laboratory costs: With a 34% return rate, one can assume about 300 additional tests, which equates (at $30 per test for CT/GC and Trich)

Programming Continued… Advertising Costs Toll Free Line Rudimentary Budget Includes: –Kits $6,000 (assuming $1000 sent) –Lab $9,000 (assuming 34% return rate) –Advertising: $1,000 (based on MD budget) –Toll Free –TOTAL: $17,000 plus staff time

Acknowledgements Bulbul Aumakhan Jeff Holden Nicole Quinn Andrew Hardick